0001104659-21-110596.txt : 20210827
0001104659-21-110596.hdr.sgml : 20210827
20210827170125
ACCESSION NUMBER: 0001104659-21-110596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210825
FILED AS OF DATE: 20210827
DATE AS OF CHANGE: 20210827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coiante Scott M
CENTRAL INDEX KEY: 0001608536
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 211219927
MAIL ADDRESS:
STREET 1: 101 POOR FARM ROAD 3RD FLOOR
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
tm2126037-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-08-25
0
0001781983
Aprea Therapeutics, Inc.
APRE
0001608536
Coiante Scott M
535 BOYLSTON STREET
BOSTON
MA
02116
0
1
0
0
SVP, Chief Financial Officer
Common Stock
2021-08-25
4
F
0
7534
3.98
D
91466
D
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 21,166 restricted stock units.
/s/ Scott M. Coiante
2021-08-27